Inhibition of COX‐2 expression by endocannabinoid 2‐arachidonoylglycerol is mediated via PPAR‐γ
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND PURPOSE Endocannabinoids have both anti‐inflammatory and neuroprotective properties against harmful stimuli. We previously demonstrated that the endocannabinoid 2‐arachidonoylglycerol (2‐AG) protects hippocampal neurons by limiting the inflammatory response via a CB 1 receptor‐dependent MAPK/NF‐κB signalling pathway. The purpose of the present study was to determine whether PPARγ, an important nuclear receptor, mediates 2‐AG‐induced inhibition of NF‐κB phosphorylation and COX‐2 expression, and COX‐2‐enhanced miniature spontaneous excitatory postsynaptic currents (mEPSCs). EXPERIMENTAL APPROACH By using a whole‐cell patch clamp electrophysiological recording technique and immunoblot analysis, we determined mEPSCs, expression of COX‐2 and PPARγ, and phosphorylation of NF‐kB in mouse hippocampal neurons in culture. KEY RESULTS Exogenous and endogenous 2‐AG‐produced suppressions of NF‐κB‐p65 phosphorylation, COX‐2 expression and excitatory synaptic transmission in response to pro‐inflammatory interleukin‐1β (IL‐1β) and LPS were inhibited by GW9662, a selective PPARγ antagonist, in hippocampal neurons in culture. PPARγ agonists 15‐deoxy‐Δ 12,14‐prostaglandin J 2(15d‐PGJ 2) and rosiglitazone mimicked the effects of 2‐AG on NF‐κB‐p65 phosphorylation, COX‐2 expression and mEPSCs, and these effects were eliminated by antagonism of PPARγ. Moreover, exogenous application of 2‐AG or elevation of endogenous 2‐AG by inhibiting its hydrolysis with URB602 or JZL184, selective inhibitors of monoacylglycerol lipase (MAGL), prevented the IL‐1β‐ and LPS‐induced reduction of PPARγ expression. The 2‐AG restoration of the reduced PPARγ expression was blocked or attenuated by pharmacological or genetic inhibition of the CB 1 receptor. CONCLUSIONS AND IMPLICATIONS Our results suggest that CB 1 receptor‐dependent PPARγ expression is an important and novel signalling pathway in endocannabinoid 2‐AG‐produced resolution of neuroinflammation in response to pro‐inflammatory insults. LINKED ARTICLES This article is part of a themed issue on Cannabinoids in Biology and Medicine. To view the other articles in this issue visit http://dx.doi.org/10.1111/bph.2011.163.issue‐7
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
The molecular logic of endocannabinoid signalling
Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957 · cited 2×
“While eCB modulation of both GABAergic and glutamatergic synaptic transmission and plasticity via a CB1 receptordependent mechanism has been extensively investigated (Alger, 2002; Freund et al., 2003; Piomelli, 2003; Chevaleyre et al., 2006; Mackie, 2006; Kano et al., 2009), the mechanisms underlying the ability of eC…”
BackgroundGuide to receptors and channels (GRAC), 5th edition
Alexander, S., Mathie, A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_1.x · Cited by 1,947
Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb
Jiang, J., & Struhl, G. (1998) · Nature · doi:10.1038/35154 · Cited by 1,735
CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., Azad, S. C., Cascio, M. G., Gutiérrez, S. O., van der Stelt, M., et al. (2003) · Science · doi:10.1126/science.1088208 · Cited by 1,208 · cited 2×
“Emerging evidence now suggests that eCBs possess anti-inflammatory and neuroprotective properties against harmful insults (Marsicano et al., 2003; Walter and Stella, 2004; Panikashvili et al., 2001; 2005, 2006; Eljaschewitsch et al., 2006; Mackie, 2006; Centonze et al., 2007; Zhang and Chen, 2008;…”
BackgroundA Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol
Blankman, J. L., Simon, G. M., & Cravatt, B. F. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.11.006 · Cited by 1,177 · cited 1×
“MAGL is the enzyme that hydrolyzes 85% of 2-AG in the brain British Journal of Pharmacology (2011) 163 1533–1549 1537 1538 British Journal of Pharmacology (2011) 163 1533–1549 (Blankman et al., 2007).”
BackgroundAn endocannabinoid mechanism for stress-induced analgesia
Hohmann, A. G., Suplita, R. L., Bolton, N. M., Neely, M. H., Fegley, D., Mangieri, R., Krey, J. F., Michael Walker, J., Holmes, P. V., Crystal, J. D., et al. (2005) · Nature · doi:10.1038/nature03658 · Cited by 778 · cited 2×
“Thus, inhibiting MAGL with selective MAGL inhibitors will raise the levels of endogenous 2-AG (Hohmann et al., 2005; Comelli et al., 2007; King et al., 2007; Long et al., 2009a; 2009b; Pan et al., 2009).”
BackgroundMethodEljaschewitsch, E., Witting, A., Mawrin, C., Lee, T., Schmidt, P. M., Wolf, S., Hoertnagl, H., Raine, C. S., Schneider-Stock, R., Nitsch, R., et al. (2006) · Neuron · doi:10.1016/j.neuron.2005.11.027 · Cited by 445 · cited 3×
“…suggests that eCBs possess anti-inflammatory and neuroprotective properties against harmful insults (Marsicano et al., 2003; Walter and Stella, 2004; Panikashvili et al., 2001; 2005, 2006; Eljaschewitsch et al., 2006; Mackie, 2006; Centonze et al., 2007; Zhang and Chen, 2008; Chen et al., 2011).”
BackgroundLee, G., Elwood, F., McNally, J., Weiszmann, J., Lindstrom, M., Amaral, K., Nakamura, M., Miao, S., Cao, P., Learned, R. M., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200743200 · Cited by 319 · cited 4×
“To further ascertain the effect of PPARg inhibition on 2-AGinduced suppression of mEPSCs in IL-1b- or LPS-treated cultures, we used another selective PPARg antagonist, T0070907 (T007) (Lee et al., 2002).”
MethodInfluential
Cited by
An update on PPAR activation by cannabinoids
O'Sullivan, S. E. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13497 · Cited by 449
Endocannabinoid signalling and the deteriorating brain
Di Marzo, V., Stella, N., & Zimmer, A. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3876 · Cited by 382
Why do cannabinoid receptors have more than one endogenous ligand?
Di Marzo, V., & De Petrocellis, L. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0382 · Cited by 290
Monoacylglycerol Lipase Is a Therapeutic Target for Alzheimer's Disease
Chen, R., Zhang, J., Wu, Y., Wang, D., Feng, G., Tang, Y.-P., Teng, Z., & Chen, C. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.030 · Cited by 271
Self-citationCOX-2-derived endocannabinoid metabolites as novel inflammatory mediators
Alhouayek, M., & Muccioli, G. G. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.03.001 · Cited by 252
Metadata
- Authors
- Du, H., Chen, X., Zhang, J., & Chen, C.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2011-07-12
- Volume
- 163
- Issue
- 7
- Pages
- 1533-1549
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1546632148
- Cited by
- 134
- References
- 16
- FWCI
- 6.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of COX‐2 expression by endocannabinoid 2‐arachidonoylglycerol is mediated via PPAR‐γ. https://app.cochat.ai/papers/10.1111/j.1476-5381.2011.01444.x
- The paper
- Du, H., Chen, X., Zhang, J., & Chen, C. (2011). Inhibition of COX‐2 expression by endocannabinoid 2‐arachidonoylglycerol is mediated via PPAR‐γ. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2011.01444.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.